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Background
Broadly neutralizing antibodies (bNAbs) against HIV-1
are not efficiently elicited by vaccination despite consider-
able efforts. bNAb elicitation is likely limited both by cur-
rent envelope glycoproteins (Env) immunogens, which
are not sufficient mimics of the native Env spike complex,
and by the lack of immunization regimens that promote
optimal development and maturation of B cell responses.
So far, analyses from protein immunization studies focus
mainly on serological antibody responses and less on
responses at the B cell level. Here, we characterize frequen-
cies of antigen-specific antibody secreting cells (ASC) and
memory B cells in the periphery and bone marrow of rhe-
sus macaques immunized with soluble gp140 trimers.
These analyses provide a foundation for the design of
improved immunization protocols to elicit bNAbs against
HIV-1.
Methods
We established stimulation protocols for in vitro expan-
sion and differentiation of macaque memory B cells into
ASC to allow enumeration and monitoring of memory B
cells post immunization. Using a series of variant Env
probes, the frequencies of B cells specific for different
structural determinants of Env were quantitated by B cell
ELISpot analysis.
Results
By stimulating peripheral PBMCs with a mitogen cocktail
we detected Env-specific memory B cells at a sensitivity of
~0.1% of the total number of memory cells. By sampling
peripheral PBMCs at several time points after soluble
gp140 trimer immunization we demonstrate that ASC
peak one week after immunization while memory B cell
responses peak between one and two weeks after immuni-
zation. The peripheral gp140-specific memory B cell pool
constitutes between 10 to 20% of the total peripheral
memory B cell pool.
Conclusion
By establishing in vitro stimulation protocols for rhesus
memory B cells, and determining the peak of antigen spe-
cific responses after protein vaccination, we describe a
benchmark study that can be used to inform future analy-
ses of vaccine-elicited B cell responses in primates.
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